AA Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
4,132
+108
+3% +$23.2K 0.13% 109
2026
Q1
$875K Buy
4,024
+407
+11% +$90.3K 0.12% 117
2025
Q4
$827K Buy
3,617
+959
+36% +$218K 0.15% 101
2025
Q3
$615K Sell
2,658
-864
-25% -$176K 0.12% 104
2025
Q2
$654K Sell
3,522
-899
-20% -$167K 0.14% 91
2025
Q1
$926K Sell
4,421
-621
-12% -$121K 0.23% 73
2024
Q4
$896K Sell
5,042
-91
-2% -$16.7K 0.24% 71
2024
Q3
$1.01M Sell
5,133
-100
-2% -$18.7K 0.29% 67
2024
Q2
$898K Buy
5,233
+809
+18% +$134K 0.32% 67
2024
Q1
$806K Buy
+4,424
New +$762K 0.33% 72

Other funds holding ABBV

AA Financial Advisors's ABBV Position: Q2 2026 in Review

AA Financial Advisors increased its AbbVie (ABBV) stake by 2.7% in Q2 2026, buying an estimated $23.2K and bringing the position to 4,132 shares worth $1.04M. The position accounts for 0.13% of the portfolio, ranked #109.

AA Financial Advisors first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AA Financial Advisors held 4,132 shares of AbbVie worth $1.04M as of Q2 2026.
  • AA Financial Advisors bought 108 AbbVie shares in Q2 2026, an estimated $23.2K.
  • AbbVie made up 0.13% of AA Financial Advisors's portfolio in Q2 2026, its #109 holding.
  • AA Financial Advisors first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AA Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.